Loading data
SCNINasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.31 m USD | 658 k USD | — | — | — |
| Cost of revenue | 3.96 m USD | 1.24 m USD | — | — | — |
| Gross profit | -2.65 m USD | -580 k USD | — | — | — |
| Research and development expense | 2.37 m USD | 5.53 m USD | 5.21 m USD | 5.77 m USD | 3.25 m USD |
| Selling, general and administrative expense | 2.52 m USD | 2.53 m USD | 4.51 m USD | 5.3 m USD | 7.63 m USD |
| Operating profit | -7.54 m USD | -8.64 m USD | -9.71 m USD | -11.06 m USD | -10.86 m USD |
| Interest expense | — | — | 343 k USD | 351 k USD | 336 k USD |
| Net income (reported basis) | -8.31 m USD | 4.8 m USD | -6.5 m USD | -5.8 m USD | -8.21 m USD |
| Net income attributable to common shareholders | — | — | 6.5 m USD | 5.8 m USD | 8.21 m USD |
| Basic earnings per share | — | — | 0 USD/share | 0.01 USD/share | -0.02 USD/share |
| Diluted earnings per share | — | — | 0 USD/share | 0.01 USD/share | -0.02 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.